The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
As providers become more comfortable with delivering care via telemedicine, telehealth, and digital health technologies, some are exploring services beyond low acuity consults. One area of opportunity ...
The American Telemedicine Association announced that the U.S. Drug Enforcement Administration, or DEA, granted a 1-year extension for remote prescribing of controlled medications just before the ...
On January 16, the U.S. Drug Enforcement Administration (DEA) announced three new telemedicine rules that extend prescribing flexibilities for controlled substances, following the expiration of ...
DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.
The US Drug Enforcement Administration (DEA) further extended flexibilities that allow providers to prescribe controlled substances via telemedicine without first performing an in-person visit. The ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The Drug Enforcement Administration is reaching the final steps of its proposed rulemaking process for the prescription of controlled substances via telehealth, but its plans have been leaked. The ...
The U.S. Drug Enforcement Administration has proposed two rules for prescribing controlled substances set to go into effect on May 11, according to a March 7 report from Medscape, but the proposals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results